Novo Nordisk
Gold, silver, and copper hit record highs; strong GDP data weighs on US stock futures | Tonight's Highlights
1. Metals surge continues, with spot gold, silver, and LME copper all hitting record highs; 2. US Q3 GDP data exceeds e...
The first oral weight-loss drug has received FDA approval! Novo Nordisk shares surge nearly 10% in after-hours trading.
With the approval of the first GLP-1 oral weight-loss drug by US regulators Novo Nordisk , the Danish pharmaceutical gi...
Novo Nordisk's stock price has fallen back to 2021 levels; analysts are cautiously optimistic about valuation recovery.
Danish pharmaceutical giant Novo Nordisk This year, the stock price plummeted, even regressing to levels seen in 2021 f...
A massive sell-off hit Novo Nordisk, causing its stock price to plummet! The outcome of the "weight-loss drug war" is now decided.
A mega-cap company was suddenly hit by a massive sell-off. On November 24th, Eastern Time, Danish pharmaceutical giant ...
US pre-market trading: Futures for all three major stock indices rise; Goldman Sachs' latest analysis predicts the Fed will cut interest rates in December.
U.S. stock index futures rose across the board in pre-market trading on Monday, while major European indices also gener...
Facing slowing performance and a halved stock price, Novo Nordisk's CFO stated that the key to the future lies in next-generation weight loss drugs.
① Facing competition from rivals eroding its market share, Danish pharmaceutical giant Novo Nordisk... ① The company is...
A crucial bidding war for weight-loss drugs: Pfizer may raise its bid to compete with Novo Nordisk for Metsera.
The bidding war surrounding obesity biotechnology company Metsera is intensifying, with reports indicating that Pfizer....
US pre-market: Futures for the three major stock indexes are mixed; US October ADP employment figures exceed expectations.
U.S. stock index futures were mixed in pre-market trading on Wednesday, while most major European indices declined. As ...
New CEO throws cold water on things right after taking office? Novo Nordisk lowers growth forecast for weight loss drugs.
①Novo Nordisk The third-quarter financial report showed that its quarterly sales increased by 15% year-on-year, of whic...
Novo Nordisk's "hijacking" of Pfizer's acquisition sparks a surge in the valuation of weight loss therapy assets.
On October 31, Pfizer For US weight loss drug manufacturer Metsera and Danish pharmaceutical giant Novo Nordisk Novo No...
Novo Nordisk outbids Pfizer for $4.9 billion to acquire US company Metsera.
①Novo Nordisk, the Danish pharmaceutical giant ① Novo Nordisk made an all-cash offer of $56.50 per share to acquire the...
Novo Nordisk may face a major personnel upheaval at the top due to a failure to reach an agreement on the future composition of its board of directors.
A statement from an industry giant has shocked the global pharmaceutical industry. On the 21st, Novo Nordisk... Novo No...